PROCEPT BioRobotics Statistics
Total Valuation
PRCT has a market cap or net worth of $3.50 billion. The enterprise value is $3.36 billion.
| Market Cap | 3.50B |
| Enterprise Value | 3.36B |
Important Dates
The last earnings date was Wednesday, May 1, 2024, before market open.
| Earnings Date | May 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PRCT has 51.42 million shares outstanding. The number of shares has increased by 13.19% in one year.
| Shares Outstanding | 51.42M |
| Shares Change (YoY) | +13.19% |
| Shares Change (QoQ) | +0.76% |
| Owned by Insiders (%) | 4.05% |
| Owned by Institutions (%) | 87.61% |
| Float | 46.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 22.41 |
| Forward PS | 14.91 |
| PB Ratio | 13.27 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 21.49 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.52, with a Debt / Equity ratio of 0.31.
| Current Ratio | 8.52 |
| Quick Ratio | 7.29 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -23.88 |
Financial Efficiency
Return on equity (ROE) is -41.30% and return on invested capital (ROIC) is -31.39%.
| Return on Equity (ROE) | -41.30% |
| Return on Assets (ROA) | -27.90% |
| Return on Capital (ROIC) | -31.39% |
| Revenue Per Employee | $249,722 |
| Profits Per Employee | -$165,125 |
| Employee Count | 626 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 1.81 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +109.60% in the last 52 weeks. The beta is 0.95, so PRCT's price volatility has been similar to the market average.
| Beta (1Y) | 0.95 |
| 52-Week Price Change | +109.60% |
| 50-Day Moving Average | 53.41 |
| 200-Day Moving Average | 41.68 |
| Relative Strength Index (RSI) | 71.31 |
| Average Volume (30 Days) | 575,770 |
Short Selling Information
The latest short interest is 5.66 million, so 11.00% of the outstanding shares have been sold short.
| Short Interest | 5.66M |
| Short Previous Month | 5.36M |
| Short % of Shares Out | 11.00% |
| Short % of Float | 12.26% |
| Short Ratio (days to cover) | 10.53 |
Income Statement
In the last 12 months, PRCT had revenue of $156.33 million and -$103.37 million in losses. Loss per share was -$2.12.
| Revenue | 156.33M |
| Gross Profit | 83.59M |
| Operating Income | -108.44M |
| Pretax Income | -103.37M |
| Net Income | -103.37M |
| EBITDA | -95.59M |
| EBIT | -99.21M |
| Loss Per Share | -$2.12 |
Balance Sheet
The company has $225.58 million in cash and $81.39 million in debt, giving a net cash position of $144.19 million or $2.80 per share.
| Cash & Cash Equivalents | 225.58M |
| Total Debt | 81.39M |
| Net Cash | 144.19M |
| Net Cash Per Share | $2.80 |
| Equity / Book Value | 264.05M |
| Book Value Per Share | 5.13 |
| Working Capital | 290.54M |
Cash Flow
In the last 12 months, operating cash flow was -$104.36 million and capital expenditures -$21.81 million, giving a free cash flow of -$126.17 million.
| Operating Cash Flow | -104.36M |
| Capital Expenditures | -21.81M |
| Free Cash Flow | -126.17M |
| FCF Per Share | -$2.47 |
Margins
Gross margin is 53.47%, with operating and profit margins of -69.37% and -66.12%.
| Gross Margin | 53.47% |
| Operating Margin | -69.37% |
| Pretax Margin | -66.12% |
| Profit Margin | -66.12% |
| EBITDA Margin | -61.15% |
| EBIT Margin | -63.47% |
| FCF Margin | -80.71% |
Dividends & Yields
PRCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.19% |
| Shareholder Yield | -13.19% |
| Earnings Yield | -2.95% |
| FCF Yield | -3.60% |
Analyst Forecast
The average price target for PRCT is $61.20, which is -10.13% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | $61.20 |
| Price Target Difference | -10.13% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 33.11% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PRCT has an Altman Z-Score of 16.39 and a Piotroski F-Score of 3.
| Altman Z-Score | 16.39 |
| Piotroski F-Score | 3 |